Fewer asymptomatic cases than previously believed. Plus, Europe's second wave could crash harder than the first.
New research shows there are fewer asymptomatic COVID-19 cases than previously thought.
Could Europe's second wave hit harder than the first?
Stanford scientists discuss their role in the Johnson & Johnson Phase 3 vaccine trial.
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
Activity